mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.1 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.22 |
0.2 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.2 |